Filtros : "CARDIOLOGIA" "Inglês" "INSUFICIÊNCIA CARDÍACA" Limpar

Filtros



Refine with date range


  • Source: Sao paulo medical journal. Unidade: FM

    Subjects: INSUFICIÊNCIA CARDÍACA, DISPOSITIVOS E INSTRUMENTOS MÉDICOS, CARDIOLOGIA

    Acesso à fonteAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      FERREIRA, Silvia Moreira Ayub e FERNANDES, Paulo Manuel Pego. Long-term mechanical assisted circulation devices. [Editorial]. Sao paulo medical journal. Sao Paulo: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://doi.org/10.1590/1516-3180.2022.140303122021. Acesso em: 28 set. 2024. , 2022
    • APA

      Ferreira, S. M. A., & Fernandes, P. M. P. (2022). Long-term mechanical assisted circulation devices. [Editorial]. Sao paulo medical journal. Sao Paulo: Faculdade de Medicina, Universidade de São Paulo. doi:10.1590/1516-3180.2022.140303122021
    • NLM

      Ferreira SMA, Fernandes PMP. Long-term mechanical assisted circulation devices. [Editorial] [Internet]. Sao paulo medical journal. 2022 ; 140( 3): 329-330.[citado 2024 set. 28 ] Available from: https://doi.org/10.1590/1516-3180.2022.140303122021
    • Vancouver

      Ferreira SMA, Fernandes PMP. Long-term mechanical assisted circulation devices. [Editorial] [Internet]. Sao paulo medical journal. 2022 ; 140( 3): 329-330.[citado 2024 set. 28 ] Available from: https://doi.org/10.1590/1516-3180.2022.140303122021
  • Source: European heart journal. Unidade: FM

    Subjects: CARDIOLOGIA, INSUFICIÊNCIA CARDÍACA, CORONAVIRUS, COVID-19

    Acesso à fonteAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      ANKER, Stefan D et al. Conducting clinical trials in heart failure during (and after) the COVID-19 pandemic: an Expert Consensus Position Paper from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC). European heart journal, v. 41, n. 22, p. 2109-2117, 2020Tradução . . Disponível em: https://doi.org/10.1093/eurheartj/ehaa461. Acesso em: 28 set. 2024.
    • APA

      Anker, S. D., Butler, J., Khan, M. S., Abraham, W. T., Bauersachs, J., Bocchi, E. A., et al. (2020). Conducting clinical trials in heart failure during (and after) the COVID-19 pandemic: an Expert Consensus Position Paper from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC). European heart journal, 41( 22), 2109-2117. doi:10.1093/eurheartj/ehaa461
    • NLM

      Anker SD, Butler J, Khan MS, Abraham WT, Bauersachs J, Bocchi EA, Bozkurt B, Braunwald E, Chopra VK, Cleland JG. Conducting clinical trials in heart failure during (and after) the COVID-19 pandemic: an Expert Consensus Position Paper from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC) [Internet]. European heart journal. 2020 ; 41( 22): 2109-2117.[citado 2024 set. 28 ] Available from: https://doi.org/10.1093/eurheartj/ehaa461
    • Vancouver

      Anker SD, Butler J, Khan MS, Abraham WT, Bauersachs J, Bocchi EA, Bozkurt B, Braunwald E, Chopra VK, Cleland JG. Conducting clinical trials in heart failure during (and after) the COVID-19 pandemic: an Expert Consensus Position Paper from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC) [Internet]. European heart journal. 2020 ; 41( 22): 2109-2117.[citado 2024 set. 28 ] Available from: https://doi.org/10.1093/eurheartj/ehaa461
  • Source: PLOS ONE. Unidade: EEFE

    Subjects: DOENÇAS CARDIOVASCULARES, ADRENÉRGICOS, CARDIOLOGIA, INSUFICIÊNCIA CARDÍACA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      GAVIOLI, Mariana et al. Cholinergic signaling exerts protective effects in models of sympathetic hyperactivity-induced cardiac dysfunction. PLOS ONE, v. 9, n. 7, p. 9 , 2014Tradução . . Disponível em: https://doi.org/10.1371/journal.pone.0100179. Acesso em: 28 set. 2024.
    • APA

      Gavioli, M., Lara, A., Almeida, P. W. M., Lima, A. M., Damasceno, D. D., Rocha-Resende, C., et al. (2014). Cholinergic signaling exerts protective effects in models of sympathetic hyperactivity-induced cardiac dysfunction. PLOS ONE, 9( 7), 9 . doi:10.1371/journal.pone.0100179
    • NLM

      Gavioli M, Lara A, Almeida PWM, Lima AM, Damasceno DD, Rocha-Resende C, Ladeira M, Resende RR, Martinelli PM, Melo MB, Brum PC, Fontes MAP, Santos RAS, Prado MAM, Guatimosim S. Cholinergic signaling exerts protective effects in models of sympathetic hyperactivity-induced cardiac dysfunction [Internet]. PLOS ONE. 2014 ; 9( 7): 9 .[citado 2024 set. 28 ] Available from: https://doi.org/10.1371/journal.pone.0100179
    • Vancouver

      Gavioli M, Lara A, Almeida PWM, Lima AM, Damasceno DD, Rocha-Resende C, Ladeira M, Resende RR, Martinelli PM, Melo MB, Brum PC, Fontes MAP, Santos RAS, Prado MAM, Guatimosim S. Cholinergic signaling exerts protective effects in models of sympathetic hyperactivity-induced cardiac dysfunction [Internet]. PLOS ONE. 2014 ; 9( 7): 9 .[citado 2024 set. 28 ] Available from: https://doi.org/10.1371/journal.pone.0100179
  • Source: PLOS ONE. Unidade: EEFE

    Subjects: INSUFICIÊNCIA CARDÍACA, CARDIOLOGIA

    Acesso à fonteAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      FERREIRA, Julio Cesar Batista et al. Protein quality control disruption by PKCβII in heart failure; rescue by the selective PKCβII inhibitor, βIIV5-3. PLOS ONE, v. 7, n. 3, p. 1-9, 2012Tradução . . Disponível em: https://doi.org/10.1371/journal.pone.0033175. Acesso em: 28 set. 2024.
    • APA

      Ferreira, J. C. B., Boer, B. N., Grinberg, M., Brum, P. C., & Mochly-Rosen, D. (2012). Protein quality control disruption by PKCβII in heart failure; rescue by the selective PKCβII inhibitor, βIIV5-3. PLOS ONE, 7( 3), 1-9. doi:10.1371/journal.pone.0033175
    • NLM

      Ferreira JCB, Boer BN, Grinberg M, Brum PC, Mochly-Rosen D. Protein quality control disruption by PKCβII in heart failure; rescue by the selective PKCβII inhibitor, βIIV5-3 [Internet]. PLOS ONE. 2012 ; 7( 3): 1-9.[citado 2024 set. 28 ] Available from: https://doi.org/10.1371/journal.pone.0033175
    • Vancouver

      Ferreira JCB, Boer BN, Grinberg M, Brum PC, Mochly-Rosen D. Protein quality control disruption by PKCβII in heart failure; rescue by the selective PKCβII inhibitor, βIIV5-3 [Internet]. PLOS ONE. 2012 ; 7( 3): 1-9.[citado 2024 set. 28 ] Available from: https://doi.org/10.1371/journal.pone.0033175
  • Source: Journal of Molecular and Cellular Cardiology. Unidade: EEFE

    Subjects: FARMACOLOGIA, FISIOLOGIA, INSUFICIÊNCIA CARDÍACA, CARDIOLOGIA

    Acesso à fonteAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      FERREIRA, Julio Cesar Batista e BRUM, Patricia Chakur e MOCHLY-ROSEN, Daria. 'beta' IIPKC and 'épsilon' PKC isozymes as potential pharmacological targets in cardiac hypertrophy and heart failure. Journal of Molecular and Cellular Cardiology, v. 51, p. 479-484, 2011Tradução . . Disponível em: http://ac.els-cdn.com/S0022282810003998/1-s2.0-S0022282810003998-main.pdf?_tid=3405d86058fa5d8193f1f43cdbe58326&acdnat=1342119331_155a76a1dea8dac900622cc4ec7fbc0e. Acesso em: 28 set. 2024.
    • APA

      Ferreira, J. C. B., Brum, P. C., & Mochly-Rosen, D. (2011). 'beta' IIPKC and 'épsilon' PKC isozymes as potential pharmacological targets in cardiac hypertrophy and heart failure. Journal of Molecular and Cellular Cardiology, 51, 479-484. doi:10.1016/j.yjmcc.2010.10.020
    • NLM

      Ferreira JCB, Brum PC, Mochly-Rosen D. 'beta' IIPKC and 'épsilon' PKC isozymes as potential pharmacological targets in cardiac hypertrophy and heart failure [Internet]. Journal of Molecular and Cellular Cardiology. 2011 ; 51 479-484.[citado 2024 set. 28 ] Available from: http://ac.els-cdn.com/S0022282810003998/1-s2.0-S0022282810003998-main.pdf?_tid=3405d86058fa5d8193f1f43cdbe58326&acdnat=1342119331_155a76a1dea8dac900622cc4ec7fbc0e
    • Vancouver

      Ferreira JCB, Brum PC, Mochly-Rosen D. 'beta' IIPKC and 'épsilon' PKC isozymes as potential pharmacological targets in cardiac hypertrophy and heart failure [Internet]. Journal of Molecular and Cellular Cardiology. 2011 ; 51 479-484.[citado 2024 set. 28 ] Available from: http://ac.els-cdn.com/S0022282810003998/1-s2.0-S0022282810003998-main.pdf?_tid=3405d86058fa5d8193f1f43cdbe58326&acdnat=1342119331_155a76a1dea8dac900622cc4ec7fbc0e
  • Source: Journal of Molecular and Cellular Cardiology. Unidade: EEFE

    Subjects: FARMACOLOGIA, HIPERTENSÃO, INSUFICIÊNCIA CARDÍACA, CARDIOLOGIA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      FERREIRA, Julio Cesar Batista et al. Pharmacological inhibition of BIIPKC is cardioprotective in late-stage hypertrophy. Journal of Molecular and Cellular Cardiology, v. 51, p. 980-987, 2011Tradução . . Disponível em: https://doi.org/10.1016/j.yjmcc.2011.08.025. Acesso em: 28 set. 2024.
    • APA

      Ferreira, J. C. B., Koyanagi, T., Palaniyandi, S. S., Fajardo, G., Brum, P. C., & Mochly-Rosen, D. (2011). Pharmacological inhibition of BIIPKC is cardioprotective in late-stage hypertrophy. Journal of Molecular and Cellular Cardiology, 51, 980-987. doi:10.1016/j.yjmcc.2011.08.025
    • NLM

      Ferreira JCB, Koyanagi T, Palaniyandi SS, Fajardo G, Brum PC, Mochly-Rosen D. Pharmacological inhibition of BIIPKC is cardioprotective in late-stage hypertrophy [Internet]. Journal of Molecular and Cellular Cardiology. 2011 ; 51 980-987.[citado 2024 set. 28 ] Available from: https://doi.org/10.1016/j.yjmcc.2011.08.025
    • Vancouver

      Ferreira JCB, Koyanagi T, Palaniyandi SS, Fajardo G, Brum PC, Mochly-Rosen D. Pharmacological inhibition of BIIPKC is cardioprotective in late-stage hypertrophy [Internet]. Journal of Molecular and Cellular Cardiology. 2011 ; 51 980-987.[citado 2024 set. 28 ] Available from: https://doi.org/10.1016/j.yjmcc.2011.08.025
  • Conference titles: European Society of Cardiology Congress. Unidade: EEFE

    Subjects: INSUFICIÊNCIA CARDÍACA, CARDIOLOGIA

    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      ALVES, M J N Nunes et al. The blunted muscle vasodilatation during hypoxia in heart failure patients is mediated by sympathetic activation and endothelial dysfunction. 2010, Anais.. Estocolmo: European Society of Cardiology, 2010. . Acesso em: 28 set. 2024.
    • APA

      Alves, M. J. N. N., Santos, M. R. dos, Nobre, T. S., Martinez, D. G., Rondon, M. U., Brum, P. C., et al. (2010). The blunted muscle vasodilatation during hypoxia in heart failure patients is mediated by sympathetic activation and endothelial dysfunction. In . Estocolmo: European Society of Cardiology.
    • NLM

      Alves MJNN, Santos MR dos, Nobre TS, Martinez DG, Rondon MU, Brum PC, Barretto ACP, Middlekauff H, Negrão CE. The blunted muscle vasodilatation during hypoxia in heart failure patients is mediated by sympathetic activation and endothelial dysfunction. 2010 ;[citado 2024 set. 28 ]
    • Vancouver

      Alves MJNN, Santos MR dos, Nobre TS, Martinez DG, Rondon MU, Brum PC, Barretto ACP, Middlekauff H, Negrão CE. The blunted muscle vasodilatation during hypoxia in heart failure patients is mediated by sympathetic activation and endothelial dysfunction. 2010 ;[citado 2024 set. 28 ]
  • Source: European Respiratory Journal. Unidade: EEFE

    Subjects: INSUFICIÊNCIA CARDÍACA, CARDIOLOGIA

    Acesso à fonteAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      CASTRO, R R T et al. Ventilation variability inversely correlates to ejection fraction in heart failure. European Respiratory Journal, v. 36, n. 6, p. 1482-1483, 2010Tradução . . Disponível em: https://doi.org/10.1183/09031936.00044910. Acesso em: 28 set. 2024.
    • APA

      Castro, R. R. T., Antunes-Correa, L. M., Ueno, L. M., Rondon, M. U. P. B., Negrão, C. E., & Nobrega, A. C. L. (2010). Ventilation variability inversely correlates to ejection fraction in heart failure. European Respiratory Journal, 36( 6), 1482-1483. doi:10.1183/09031936.00044910
    • NLM

      Castro RRT, Antunes-Correa LM, Ueno LM, Rondon MUPB, Negrão CE, Nobrega ACL. Ventilation variability inversely correlates to ejection fraction in heart failure [Internet]. European Respiratory Journal. 2010 ; 36( 6): 1482-1483.[citado 2024 set. 28 ] Available from: https://doi.org/10.1183/09031936.00044910
    • Vancouver

      Castro RRT, Antunes-Correa LM, Ueno LM, Rondon MUPB, Negrão CE, Nobrega ACL. Ventilation variability inversely correlates to ejection fraction in heart failure [Internet]. European Respiratory Journal. 2010 ; 36( 6): 1482-1483.[citado 2024 set. 28 ] Available from: https://doi.org/10.1183/09031936.00044910

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024